BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Drug Development

  Ablynx Reports Excellent Interim Results From Phase I/II Study With Its Anti-IL-6R Nanobody, ALX-0061, in Rheumatoid Arthritis Patients

  October 4, 2012

   · 

  6 min read
• Policy

  Boston Therapeutics, Inc. Wins FDA Approval to File an Abbreviated New Drug Application for PAZAMET™ to Treat Diabetes

  October 4, 2012

   · 

  4 min read
• Biotech Bay

  Threshold Pharmaceuticals, Inc. Announces Presentation and Webcast at 11th Annual Biotechnology Industry Organization (BIO) Investor Forum

  October 4, 2012

   · 

  2 min read
• Biotech Bay

  Zenmark Names Takeda Pharmaceutical Co. Ltd.'s REVESTIVE (teduglutide): a New Drug for the Treatment of Short Bowel Syndrome

  October 4, 2012

   · 

  2 min read
• Business

  Prometheus Research Joins OMNITEC Team on $20 Billion Government-Wide Acquisition Contract

  October 4, 2012

   · 

  3 min read
• Business

  BioSeek, LLC. Awarded $46 Million Five-Year Contract From EPA ToxCast™ Program

  October 4, 2012

   · 

  4 min read
• Medifocus to Attend Two Upcoming Regional American Urological Association Meetings to Promote the Prolieve® Device System

  October 4, 2012

   · 

  4 min read
• Drug Development

  Allergan Inc.'s Botox Shot Helps Overactive Bladder in Women

  October 4, 2012

   · 

  1 min read
• Biotech Beach

  Lpath, Inc. Announces Reverse Split of Class A Common Stock

  October 4, 2012

   · 

  5 min read
• Business

  NuVasive, Inc. Announces Conference Call to Discuss Preliminary Unaudited Third Quarter 2012 Revenue Results

  October 4, 2012

   · 

  5 min read